Novartis AG Minority Interest

As of the most recent data (June 2026), NVS shows a minority interest of $400M. That compares with $69M in the prior-year period — up 484.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NVS's minority interest is now $400M (was $69M) — a 484.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novartis AG is outperforming or lagging.

Tracking NVS's minority interest over time shows whether Novartis AG is scaling, shrinking, or reshaping that part of the business. The current reading is $400M That compares with $69M in the prior-year period — up 484.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Novartis AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $400M) with ownership activity and broader fundamentals.

Novartis AG's minority interest is $400M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.